Category
Bortezomib
CAS Number
862895-00-9
Molecular Formula
C19H22N4O2
Molecular Weight
338.4 g/mol
Synonym

N-[(2S)-1-[[(E)-3-methylbut-1-enyl]amino]-1-oxo-3-phenylpropan-2-yl]pyrazine-2-carboxamide; (S,E)-N-(1-((3-Methylbut-1-en-1-yl)amino)-1-oxo-3-phenylpropan-2-yl)pyrazine-2-carboxamide; Pyrazine-2-carboxamide, (S,E)-N-(1-((3-methylbut-1-en-1-yl)amino)-1-oxo-3-phenylpropan-2-yl); 2-Pyrazinecarboxamide,N-[(1S)-2-[[(1E)-3-methyl-1-buten-1-yl]amino]-2-oxo-1-(phenylmethyl)ethyl]

Keywords
Pharmaceutical Standards
Intermediates
Fine Chemicals
slide.1
Purity:

Above - 95.0%

Technical Data:

We will provide complete documentation support for every Standard Material. All analytical reports such as ¹H NMR, ¹³C NMR, Mass, FT-IR, HPLC Purity/GC Purity/QNMR Purity, Water content by KF/ Loss on Drying/TGA (Thermo-gravimetric Analysis). Certificate of Analysis with potency report. Each Standard Material SER (Structure Elucidation Report) with NMR, Mass, IR spectral interpretation. This whole analytical document can be included in eCTD, ANDA, DMF submissions to regulatory agencies.

Bortezomib Impurity 11 is a specified impurity related to Bortezomib that can form during synthesis, degradation, or storage. It has a slightly modified chemical structure compared to the active compound and is routinely monitored and controlled to ensure the drug’s quality, stability, safety, and therapeutic efficacy.